INTRA CATH-DSA INTRAVENOUS CATH PLACE.— 510(k) K823065

Substantially Equivalent

Parke-Davis Co.

FDA 510(k) clearance K823065 for INTRA CATH-DSA INTRAVENOUS CATH PLACE., Substantially Equivalent on 1982-12-15. Applicant: Parke-Davis Co..

Clearance details

Applicant: Parke-Davis Co.
Product code: Code DQO
Advisory panel: Cardiovascular
Date received: 1982-10-18
Decision date: 1982-12-15
Decision: Substantially Equivalent
Clearance type: Traditional
Location: UT, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code DQO

product code DQO

Death: 35
Injury: 993
Malfunction: 1,772
Other: 5
Total: 2,805

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.